| Dr Gene Lamar Wyse, DO | |
|
2605 2nd Ave, Kearney, NE 68847-4425 | |
| (308) 236-7016 | |
| (308) 236-7027 |
| Full Name | Dr Gene Lamar Wyse |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 2605 2nd Ave, Kearney, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093798027 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 294 (Nebraska) | Primary |
| Entity Name | State Of Nebraska Dept Of Admin Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790706034 PECOS PAC ID: 0648180828 Enrollment ID: O20040331001011 |
News Archive
UT Southwestern Medical Center investigators have uncovered new insights on adolescent fighting: what triggers it, and how to stem it. Varied real-life factors pile on daily to put teens on edge: destructive behaviors like drug abuse, drinking or high-risk sexual encounters; poverty; academic troubles; and even depression. Data analyzed by researchers at UT Southwestern suggests that when teens perceive support from their families and/or schools, it can help mitigate violence.
In this Globalist opinion piece, Ian Dowbiggin, an author and professor of history at the University of Prince Edward Island in Canada, examines the issue of "diagnostic inflation" within the psychiatry field in the last half century and how, "as Ethan Watters and others have argued, lately American psychiatry has been exporting its diagnoses and treatments to other cultures, 'homogenizing how the world goes mad.'"
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Sunesis Pharmaceuticals, Inc. and Merck & Co., Inc. have announced that they have entered into a multi-year research collaboration to discover novel oral drugs for the treatment of viral infections.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gene Lamar Wyse, DO 2605 2nd Ave, Kearney, NE 68847-4425 Ph: (308) 236-7016 | Dr Gene Lamar Wyse, DO 2605 2nd Ave, Kearney, NE 68847-4425 Ph: (308) 236-7016 |
News Archive
UT Southwestern Medical Center investigators have uncovered new insights on adolescent fighting: what triggers it, and how to stem it. Varied real-life factors pile on daily to put teens on edge: destructive behaviors like drug abuse, drinking or high-risk sexual encounters; poverty; academic troubles; and even depression. Data analyzed by researchers at UT Southwestern suggests that when teens perceive support from their families and/or schools, it can help mitigate violence.
In this Globalist opinion piece, Ian Dowbiggin, an author and professor of history at the University of Prince Edward Island in Canada, examines the issue of "diagnostic inflation" within the psychiatry field in the last half century and how, "as Ethan Watters and others have argued, lately American psychiatry has been exporting its diagnoses and treatments to other cultures, 'homogenizing how the world goes mad.'"
Ardea Biosciences, Inc. announced that it has completed formal End-of-Phase 2 meetings with the U.S. Food and Drug Administration (FDA) and successfully reached agreement on the following key aspects of its proposed lesinurad Phase 3 development plan: the overall size and design of the planned Phase 3 clinical studies, the primary endpoints, the total safety database proposed for NDA filing, manufacturing plans for both drug substance and drug product, the preclinical toxicology program and the clinical pharmacology program.
Sunesis Pharmaceuticals, Inc. and Merck & Co., Inc. have announced that they have entered into a multi-year research collaboration to discover novel oral drugs for the treatment of viral infections.
› Verified 6 days ago
Jessica Marie Hatch, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3907 6th Avenue, Kearney, NE 68845 Phone: 308-865-2767 Fax: 308-627-2765 | |
Amy Jo Herbig, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3907 6th Ave, Kearney, NE 68845 Phone: 308-865-2767 Fax: 308-865-2765 | |
Bernard Gene Keown, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 2810 W 35th St, Kearney, NE 68845 Phone: 308-865-2570 Fax: 308-865-2508 | |
Amy Lange, FNP Family Medicine Medicare: Medicare Enrolled Practice Location: 417 E 35th St, Kearney, NE 68847 Phone: 312-508-9610 | |
Rebecca Elizabeth Kahrs, APRN Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 211 W 33rd St, Kearney, NE 68845 Phone: 308-865-2141 | |
Chadd S Murray, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 816 22nd Ave, Suite 100, Kearney, NE 68845 Phone: 308-865-2263 Fax: 308-865-2541 |